Minoxidil Market Trends Growth Forecast Research 2018-2024
Date: 2018-09-28   Author: Ronak Bora  Category: #market

North America minoxidil market may witness significant growth due to its dominance in hair loss treatment industry. The region valuation for alopecia market was more than USD 2 billion in 2015. The U.S. has registered more than 45 million and 26 million cases for hair loss among men and women. However, less than 8% of them go for surgical treatments; resistance for surgery and large availability of oral drugs should optimize U.S. minoxidil market growth.

Minoxidil Market size growth will be driven by the overall demand for hair loss treatment. Dilating small blood vessels and allowing hair regrowth by enhancing cell clichés are key factors for this product, an attractive hair regrowing medication among men and women. Hectic lifestyle, change in eating habits, rising stress level and hormonal changes are responsible factors for hair loss.
 
Request for an in-depth table of contents for this report @ https://www.gminsights.com/request-toc/upcoming/750

Global alopecia (hair loss treatment) market was valued at more than USD 7.2 billion in 2015, which expects to exceed USD 10 billion revenue by 2024. Approval from FDA to be sold the medication without prescription over the counter for men and women makes the product more approachable in the market.
 
Effective results and minimal risk to health are key features fueling minoxidil demand. Global revenue from non-prescription treatments was over USD 1.2 billion in 2015. Positive outlook towards consumer purchasing power along with availability of many hair treatment processes should positively enhance minoxidil market growth.
 
According to American Hair Loss Association, worldwide more than 700 thousand people involved in hair loss treatment, androgenic alopecia holds about 90% of hair loss cases among men and women. Coronary heart disease, different types of cancer, diabetes & obesity, and high blood pressure are major factors causing hair loss.

It helps in dilating small blood vessels when used on the affected scalp areas twice daily it has been resultant to hair regrowth by enhancing cell clichés. There is also a possibility for an effect on the immune cells in the hair follicle. Usually the medication results will be visible after four months’ treatment and claimed to result in thin and fine hair than the original. However, skin irritation, itching, scalp dryness, dizziness, chest pain, and increased or decreased blood pressure are some side effects may occur on product consumption.

Request for customization @ https://www.gminsights.com/roc/750

Rogaine is an FDA approved topical product androgenic alopecia treatment produced by McNeil Consumer Healthcare, a Johnson & Johnson division. The product has 5% (male treatment) or 2% (female treatment) minoxidil, a vasodilator which improves blood flow and widens blood vessels.
 
Minoxidil market share comprises of Changland Technology, Proderma SRL, Pharhome International, McNeil Consumer Healthcare, Metapharmaceutical Ind., Suzhou Habourbiotech, Carnosine, Darkar Holdings, and Loy Pharma Lab.


About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
 



About Author


Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for AlgosOnline and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport.

...

Read More

More from Ronak